Piyasa kapalı· · CNY · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Yili Group presented a China-based model for whole-value-chain symbiosis at the Food and Agriculture Organization of the United Nations' (FAO) inaugural Global Conference for Actions on One Health in Agrifood Systems. One Health seeks to sustainably balance and optimize the health of people, animals and ecosystems, while RENOFARM is FAO's 10-year global initiative launched in 2024. Speaking at the "RENOFARM in Action" session, Yili Group Vice President XU Ke outlined three stories showing how he
Yili Group's Thailand subsidiary has received the Thailand Food and Drug Administration (FDA) Quality Award for the seventh consecutive year, earning the program's highest distinction, the "Best of the Best" Award, for the second time after first receiving the honor in 2023. This award reflects Yili's consistent commitment to quality, robust local operations and strong international growth strategy, underscoring the company's solid presence and reputation in Thailand's dairy market.
HOHHOT, China, Aug. 31, 2026 (GLOBE NEWSWIRE) -- On August 26, 2026, Yili Group released its 2026 Interim Report. In the first half of the year, the company advanced in both scale and quality, posting total revenue of RMB 64.49 billion, up 4.13% year on year, and core operating profit of RMB 8.38 billion, up 10% year on year. Yili remained Asia's No. 1 dairy company in both revenue and core operating profit, with its core operating profit margin rising 66 basis points year on year to 13%. Over t
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.